48 Post transplantation lymphoproliferative disorder with chorioretinal involvement after bone marrow transplant in a child  by Thibeault, R. et al.
$26 International Journal of Infectious Diseases (2006) 10($1 ) Abstracts 
Methods: DNA was extracted from 91 serum sam- 
pies of 52 a[[ogeneic HSCT recipients with CMV 
infection. CMV gB genotype was determined using 
po[ymerase chain reaction to amplify a region of 
UL55, foLLowed by restriction analysis based on Rsal 
and Hinfl digestion. 
Results: The distribution of gB types were as 
foLLows: gB1, 73.1% (38/52) of patients; gB2, 
13.5% (7/52); gB3, 1.9% (1/52) and mixed infection 
(gB1 and gB2), 9.6% (5/52). WhiLe gB4 was not 
detected, a new genotype (described as gB7 by 
Trincado et a[, 2000), defined on the basis of their 
restriction fragment Length po[ymorphism pattern, 
was identified. During 2-year foLLow up period, CMV 
diseases developed in 5 patients. ALL of them had 
been infected with gB1 genotype. There was no 
statisticaLLy significant association between the in- 
cidence of CMV diseases and the gB genotypes. Re- 
infection with gB1 strain was detected in a patient 
who had been previously infected with gB2. This 
episode was associated with fever, elevated Liver 
enzyme and positive antigenemia. 
Conclusion: CMV gB1 was the dominant genotype 
and gB4 was not detected in a[[ogeneic HSCT recip- 
ients in Korea. This is a unique pattern to compare 
with other reports. ALthough we can not find sig- 
nificant association between the CMV diseases and 
the gB genotypes, genotyping of CMV wiLL serve in 
the study of pathogenesis and transmission of this 
virus in the transplant patients. Further study is on 
going with Large study population. 
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Comparison of Galactomannan EIA and 
Quantitative PCR Performed on BAL Fluid for 
Diagnosing of Invasive Pulmonary Aspergillosis 
in HSCT Recipients 
A. Upton, W. Leisenring, M. Boeckh, K.A. Marr*. 
Fred Hutchinson Cancer Research Center, 
Seattle, WA, USA 
Background: Invasive pulmonary asper~iUosis (IPA) 
is a Life-threatening complication of hematopoietic 
stem ceLL transplantation (HSCT). ALthough timely 
diagnosis is often thwarted by the sub-optimaL sen- 
sitivity and specificity of conventional diagnostic 
tests, recent advances such as the ga[actomannan 
(GM) EIA and PCR assays are encouraging. 
Objectives: The aim of this study was to determine 
the sensitivity, specificity, and positive and nega- 
tive predictive values of the GM EIA and a Light- 
CycLer based quantitative PCR assay performed on 
broncho-aLveoLar [avage (BAL) fluid for diagnosing 
IA foLLowing HSCT. 
Methods: AduLt HSCT recipients undergoing bron- 
choscopy and BAL between 1st Dec 2003 and 
30th Sept 2005 were included. A GM index of 
~>0.5 was considered positive. CLinicaL data were 
coLLected by chart review. Each bronchoscopy with 
BAL was considered an episode. Positive assays 
from patients with proven or probable IA at the 
time of BAL were considered 'true-positives' while 
those from patients without IA were considered 
'faLse-positives'. Episodes of possible IA were ex- 
cluded from further analysis. 
Results: 150 patients with 211 episodes were ana- 
Lyzed. Proven, probable, possible and no IA was di- 
agnosed in 3, 29, 82, and 97 episodes, respectively. 
Performance as an aid to diagnose IPA (proven or 
probable) using the GM EIA and PCR assay were, 
respectiveLy: sensitivity 53% and 53%, specificity 
94% and 100%, positive predictive value: 74% and 
100%, and negative predictive value: 86% and 87%. 
When either a positive GM EIA or PCR assay was 
considered to be a positive test, the sensitivity, 
specificity, positive and negative predictive values 
were 69%, 94%, 79%, and 90%, respectively. 22 of 
the 32 proven or probable episodes of IA had cuL- 
ture negative BAL fluid. Of these, PCR was positive 
in 8, and GM EIA positive in 10 episodes. Thus, 
performing the GM EIA and PCR assay on BAL fluid 
increased the percentage of positive microbiology 
results by 32% and 24%, respectively. 
Conclusions: ALthough the GM and PCR assays, 
when performed on BAL fluid in high-risk patients, 
are not sufficiently sensitive to replace culture, 
they are useful adjunctive tests in making a diag- 
nosis of IPA and improve the sensitivity of culture 
alone. Combining the two tests increases the sen- 
sitivity, while maintaining exceLLent specificity. 
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Background & Methods: Epstein-Barr virus (EBV) 
associated post transplantation [ymphopro[ifera- 
tive disorder (PTLD) has emerged as an increas- 
ing cause of high morbidity and mortality in solid 
organ and bone marrow transplant (BMT) recipi- 
ents, particuLarLy in children. CLinicaL presentation 
Infections in Stem Ce[[ Transp[ant Recipients $27 
is hishLy variable; however, chorioretina[ invoLve- 
ment has been rarely described. The case: An 
8 year-oLd girt received a cord blood transpLanta- 
tion in February 2005 for a relapsing acute [ym- 
phobtastic [eukaemia. She was treated by ganci- 
c[ovir for o./tornegalovirus (CMV) reactivation from 
April to June 2005. Six months after BMT, she 
presented with prolonged fever, tonsittar necrosis, 
smaLL pulmonary nodules and positive EBV-PCR in 
blood and CSF. She underwent biLateraL tonsiLLec- 
tomy that showed poLymorphic PTLD induced by 
EBV. She was treated with monocLona[ anti-CD20 
antibody infusions and a reduction in immunosup- 
pression. ConsequentLy, she improved and EBV-PCR 
became negative. Seven months after BMT, the 
fever recurred, associated with enlarging cervical 
adenopathies nlargement, pulmonary nodules and 
positive PCR for CMV and EBV in blood. PathoLogicaL 
analysis of pulmonary nodules and cervical Lymph 
nodes biopsies confirmed PTLD. One month Later, 
the patient complained of sudden toss of decreased 
vision in her Left eye. The ophthaLmoLogic exami- 
nation showed a chorioretinitis and acute retinal 
necrosis (ARN). EBV PCR of vitreous materiel re- 
vealed high viral toad although it was negative 
in blood. The pathoLogicaL analysis of the retinal 
biopsy showed an important infiltration by [ym- 
phoproLiferatives ceLLs LMP-1 positive, but negative 
for CD20. In situ hybridization with Eber probe 
confirmed the presence of EBV. Specific treatment 
consisted of Local radiation therapy (150Gy). Five 
months after, visual acuity was 6/6 in the right eye 
and perception of hand movement at 1 meter in 
the Left eye. 
Discussion: We report a rare event of confirmed 
chorioretina[ PTLD induced by EBV after BMT in a 
child. ALthough rare, ocular PTLD should be part 
of the differential diagnosis of chorioretinitis and 
ARN in these patients. Diagnosis was confirmed 
by retinal biopsies. Positive EBV-PCR on vitreous 
fluid pleads in favour of the diagnosis and can be 
helpfuL, since there is not always a good correLa- 
tion between viral Loads in the blood and those in 
aqueous and vitreous humor. 
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Background: Invasive funsal infection (IFI) is an 
important cause of morbidity and mortality for 
hematopoietic stem ceLL transplant (HSCT) recip- 
ients with graft-versus-host disease (GVHD). Ef- 
ficacy and safety of prophylaxis with posacona- 
zoLe (POS) and fluconazoLe (FLU) were evaluated 
in HSCT recipients with GVHD in an internationaL, 
randomized, cLinicaL triaL. 
Objectives: This subanaLysis evaluated IFI develop- 
ment and associated mortality. 
Methods: Patients were randomized to receive 
POS oral suspension (200rag 3× daily) or FLU 
encapsulated tablets (400rag 1× daily) for up 
to 112 days. Primary endpoint was incidence of 
proven/probabLe IFI, determined by blinded expert 
paneL, during the primary time period (randomiza- 
tion to day 112). Incidence of proven/probabLe IFI 
was also assessed during the on-treatment phase 
(from first to Last dose plus 7 days). Deaths during 
the study were included in a mortality analysis. 
Investigators determined cause of death. 
Results: 600 patients were randomized to receive 
POS (n=301) or FLU (n=299). During the primary 
time period, prophylaxis with POS resulted in fewer 
IFIs than with FLU (5% vs 9%, P=0.07) and sig- 
nificantly fewer cases of aspersillosis (2% vs 7%, 
P =0.006). During the on-treatment phase, signifi- 
cantly fewer IFIs and cases of aspersillosis deveL- 
oped in the POS than the FLU group (2% vs 8%, 
P = 0.004; 1% vs 6%, P = 0.001, respectively). During 
the primary time period, of 16 patients in the POS 
group in whom IFI developed, 10 (63%) died; of 
27 patients in the FLU group, 18 (67%) died (tabLe). 
Among patients in whom IFI did not develop during 
the primary time period, 66/285 (23%) in the POS 
group and 66/272 (24%) in the FLU group died. 
Conclusions: In this study of HSCT recipients with 
GVHD, prophylaxis with POS resulted in fewer IFIs 
than did prophylaxis with FLU. MortaLity rates were 
higher among patients in either treatment group 
who had IFIs than those who did not. Data suggest 
early intervention such as prophylaxis with POS, 
